Capstone Investment Advisors
GMAB icon

Capstone Investment Advisors’s Genmab GMAB Stock Holding History

Capstone Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,900
Closed -$331K – 1648
2025
Q1 		$331K Buy
+16,900
New +$355K ﹤0.01% 1169
2024
Q2 		– Sell
-21,905
Closed -$655K – 2225
2024
Q1 		$655K Buy
+21,905
New +$643K ﹤0.01% 1409
2021
Q4 		– Sell
-5,323
Closed -$233K – 1943
2021
Q3 		$233K Buy
+5,323
New +$239K ﹤0.01% 1678

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Capstone Investment Advisors's GMAB Position: Q2 2025 in Review

Capstone Investment Advisors sold out of Genmab (GMAB) in Q2 2025, closing a stake of 16,900 shares — an estimated $331K sold.

Capstone Investment Advisors first reported a position in GMAB in Q3 2021 and held it in 3 quarters. The position peaked at $655K in Q1 2024. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Capstone Investment Advisors reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 16,900 Genmab shares in Q2 2025, an estimated $331K.
  • Capstone Investment Advisors first reported a position in Genmab in Q3 2021 and held it in 3 quarters.
  • Capstone Investment Advisors's Genmab position peaked at $655K in Q1 2024.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Capstone Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.